Back to Results
First PageMeta Content
Medicine / Bacitracin / Eimeria / Arsenic / Chicken / 4-Hydroxy-3-nitrobenzenearsonic acid / Chemistry / Apicomplexa / Matter


Approval Date: December 14, 2001 FREEDOM OF INFORMATION SUMMARY ORIGINAL NEW ANIMAL DRUG APPLICATION NADA[removed]Diclazuril (CLINACOXTM) plus Bacitracin Methylene Disalicylate (BMD)
Add to Reading List

Open Document

File Size: 262,83 KB

Share Result on Facebook

City

Lafayette / Rockville / Union / /

Company

Schering-Plough Animal Health Corporation / /

Event

Product Recall / Product Issues / FDA Phase / /

Facility

C. Residue Non-interference Study Schering-Plough Research Institute / /

IndustryTerm

prevention of a protozoal disease / uncooked edible by-products / combination product / /

MedicalCondition

necrotic enteritis / protozoal disease / disease / coccidiosis / infection / /

Organization

C. Residue Non-interference Study Schering-Plough Research Institute / Food and Drug Administration / US Federal Reserve / Association of American Feed Control officials / FDA / Center for Veterinary Medicine / /

Person

Chris Wrzesinski / /

Position

Director / GENERAL INFORMATION NADA / /

Product

Bacitracin / arsenic / Day-0 Withdrawal ppm Arsenic Day-3 Withdrawal ppm Day-5 / respective active ingredients / period / Nitro / animal drug / /

ProvinceOrState

New Jersey / Maryland / Indiana / /

SocialTag